-
-
Investigation of hereditary muscle disorders in the genomic era
-
Posted in Australia/New Zealand,Clinical Review Article
-
19th Aug 2020
-
Roula Ghaoui and Merrilee Needham
Posted in Australia/New Zealand,Clinical Review Article
19th Aug 2020
Roula Ghaoui and Merrilee Needham
Posted in Australia/New Zealand,Clinical Review Article
18th Aug 2020
Felix Marsh-Wakefield, Scott N Byrne, Simon Hawke and Georges Grau
Posted in Australia/New Zealand,Clinical Review Article
02nd Oct 2019
There is emerging evidence that early TPE in NMSOD relapses results in more favourable outcomes. Although the optimal timing is unclear, there is increasing evidence that early TPE within the first two days may offer the greatest degree of recovery in NMSOD relapses. Given underlying shared immunological mechanisms between NMSOD and other CNS-IDD, there may […]
Posted in Australia/New Zealand,Clinical Review Article
01st Oct 2019
Thanuja Dharmadasa and Neil G Simon
Posted in Australia/New Zealand,Clinical Review Article
02nd May 2019
Sarah Leeder
Posted in Australia/New Zealand,Clinical Review Article
17th Jan 2019
Elizabeth A McCusker
Posted in Australia/New Zealand,Clinical Review Article
11th Sep 2017
Simon Broadley, Elham Khalili, Saman Heshmat, Laura Clarke
Posted in Australia/New Zealand,Clinical Review Article
09th Jul 2017
Clare L Fraser, Adrian Cohen
Posted in Australia/New Zealand,Online First,Special Feature,Sponsored Feature
01st Feb 2017
STADA Australia continues to innovate in Parkinson’s Disease with MOVAPO® pre-filled syringes (PFS) Parkinson’s Disease is a surprisingly prevalent condition with an estimated 10 million people worldwide and roughly 70,000 Australians (1 in every 340 people) suffering from the condition.1 It is the second most prevalent neurological condition exceeded only by dementia. It is more common […]
Posted in Australia/New Zealand,Online First,Special Feature
31st Jan 2017
Aisling Murray and Thea Jones